Learn More
Medchemexpress LLC Vevorisertib | 1416775-46-6 | 98.0% | C35H38N8O | 10MG

Supplier: Medchemexpress LLC HY13745810MG
Vevorisertib is an orally active, selective pan-AKT serine/threonine kinase inhibitor provided for research use. It inhibits AKT1, AKT2, and AKT3 with low-nanomolar potency and is intended for in-vitro and preclinical studies; it is not for human use. The compound has formula C35H38N8O, molecular weight 586.73, and a reported purity of about 98%.
- Potent inhibition of AKT isoforms at low nanomolar concentrations.
- Suitable for in-vitro and preclinical cancer research.
- High chemical purity appropriate for biological testing.
- Well-characterized small-molecule with published identifiers and IUPAC name.
- Available in small pack sizes to support laboratory workflows.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.